Clinical Trials Directory

Trials / Conditions / Influenza A Virus, H5N1 Subtype

Influenza A Virus, H5N1 Subtype

7 registered clinical trials studyying Influenza A Virus, H5N1 Subtype.

StatusTrialSponsorPhase
CompletedAssess the Safety & Immunogenicity of Prime-Boost Vaccination Strategies Using H5Nx Virus Vaccine Adjuvanted W
NCT03497845
Biomedical Advanced Research and Development AuthorityPhase 2
CompletedSafety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunos
NCT02107807
SeqirusPhase 3
CompletedSystems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03)
NCT01910519
National Institute of Allergy and Infectious Diseases (NIAID)Phase 2
CompletedAn Open-Label, Randomized Phase I Study in Healthy Adults of the Safety and Immunogenicity of Prime-Boost Inte
NCT01086657
National Institute of Allergy and Infectious Diseases (NIAID)Phase 1
CompletedHost Genetic Susceptibility to Avian Influenza A/H5N1
NCT01074736
South East Asia Infectious Disease Clinical Research Network—
CompletedPhase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus
NCT00489931
National Institute of Allergy and Infectious Diseases (NIAID)Phase 1
CompletedSafety Study of Avian Flu Vaccine
NCT00408109
National Institute of Allergy and Infectious Diseases (NIAID)Phase 1